Biomea Fusion is trading at $0.56, with a -5.04% change; biotech-sector weakness is the clearest available explanation.
- Biotech ETF XBI was down 5.19% during the session.
- Major U.S. indices are higher. No company-specific announcement explaining the November 6 decline surfaced in the available search; the latest company press release found was dated October 13.
- No current trading-volume figure was available.